IVD Technology is the only trade journal designed exclusively for manufacturers of in vitro diagnostic products. Written by leading experts in their fields, IVDT?s peer-reviewed articles cover a wide range of technical and regulatory topics.
The publication?s primary focus is on diagnostics technologies--including research, development, and manufacturing. IVDT articles contain authoritative information on all aspects of manufacturing immunoassays, nucleic-acid-based diagnostics, clinical chemistry tests, and related instrumentation.
Each issue of the publication covers applied technology issues such as antibody development, substrate selection, purification, lyophilization, filtration, QA/QC, raw materials specification, clinical testing, and R&D.
Regular editorial coverage offers insights into the implications of new and pending regulations, the behind-the-scenes workings of the regulatory process, and the legal issues affecting product development and marketing. IVDT also analyzes critical business and marketing issues such as product liability, emerging markets, and other key trends.
IVD Technology Journal, Free Subscription
Qualfy for Your Free Subscription!
Geographic Eligibility: USA, Canada, Mexico, Selected International
Publisher: Canon Communications LLC
Read the Digital Issue: IVD Technology, March 2011
COVER STORY:
Detecting enzyme activity with lateral-flow immunoassays 22
Lateral-flow enzyme assay techniques retain all the benefits of LFIA, including simplicity, user-friendliness, and low cost. These assay techniques could be adapted to enzymes involved in bond formation and conformational isomerization, and they are likely to fi nd a wide variety of real-world applications.
XUEDONG SONG ON THE COVER
Adaptation of lateral-fl ow technology for enzyme assays.
Image courtesy of Kimberly-Clark Worldwide (Dallas).
Micropumps for consumable and permanent applications 28
A micropump system creates new paradigms in cost and performance profi les, opening up new possibilities in design for microfl uidic systems.
ANDY MICHALOW
Innovation helping to personalize medicine 34
In the current economic climate, IVD companies are working to help personalize medicine, which may be the most effective way to maximize care while keeping costs under control. IVD Technology?s editors identified three emerging IVD companies that offer cutting-edge, cost-effective tests.
BETH W. ORENSTEIN
Visit IVD Technology Official Web Site
In Person 18
Nonclinical Diagnostics: Adapting Clinical Technologies
Dietrich Hauffe, vice president, Applied Testing Business at Qiagen, discusses nonclinical diagnostics.
Interview by Richard Park
Regulations & Standards 14
Quality Control in Molecular Diagnostics
Molecular testing requires stringent adherence to good quality-control practices. The question is how to achieve this.
Clark A. Rundell
Final Thoughts 42
Measuring Regulatory Effectiveness
Measuring the regulatory effectiveness of IVD programs requires validating the systems in place, then comparing them to other systems.
Glen P. Freiberg
View the original article here
No comments:
Post a Comment